Viewing Study NCT02536859


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-02-04 @ 6:16 PM
Study NCT ID: NCT02536859
Status: COMPLETED
Last Update Posted: 2019-05-01
First Post: 2015-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module